First clinical trial of anticancer drug 'CAR-T' is underway for lymphoma patients

An anticancer treatment CAR-T (chimeric antigen receptor T-cell), called a miracle anticancer drug, has been developed and the first clinical trial in Korea i

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Korea ,Kim Chan Hyuk , ,Department Of Bioscience ,Korea Advanced Institute Of Science ,Global Economic ,Korea Advanced Institute ,Professor Kim Chan Hyuk ,Professor Kim ,Diffuse Largeb Cell Lymphoma ,Health News ,Oni Global ,Dancer ,The Clinical ,Nd The ,Linical ,Patients With ,Attack Cancer ,Technology ,